144 ·Filed May 15, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
This is a routine director sale with no material signal. Monitor for any subsequent Form 4 filings to confirm execution, but no trading action warranted.
Final — all horizons settled through T+60d
TVTX ▲ +41.37% at T+60d
NEUTRAL call ✓ call won +41.37% · α vs SPY +36.86% · entry $42.59 → $60.21
T+1d
+0.70%
call +0.70% · α +0.77%
$42.89
settled 5mo ago
T+5d
+4.32%
call +4.32% · α +3.36%
$44.43
settled 4mo ago
T+20d
+26.32%
call +26.32% · α +24.20%
$53.80
settled 4mo ago
T+60d
+41.37%
call +41.37% · α +36.86%
$60.21
settled 7w ago
Price Chart
Loading chart...
Executive Summary
Director Timothy Coughlin filed a Form 144 notice to sell 3,250 shares of Travere Therapeutics (TVTX) valued at approximately $141,183. The sale represents a small portion of his holdings and is routine for a director. No material impact expected.
Key Facts
- Director Timothy Coughlin filed Form 144 to sell 3,250 shares of TVTX
- Estimated sale value: $141,182.59
- Shares acquired via restricted stock awards on 11/18/2025
- Sale intended for 05/15/2026 on Nasdaq
- Broker: Wells Fargo Clearing Services
Financial Impact
Sale of 3,250 shares valued at ~$141K, representing a small fraction of director's holdings and <0.01% of TVTX's $4.1B market cap
insider holdings
Risk Factors
- Insider selling pattern could emerge if additional directors file similar notices
- Form 144 is intent to sell; sale may not be executed
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (21 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001376043-26-000004 |
| Document: 0001376043-26-000004-index.html | 0001376043-26-000004 |
| Document: 0001376043-26-000004.txt | 0001376043-26-000004 |
16 reports for TVTX
100% Hit rate best @ T+60▲ +56.24%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 9, 2026 12w ago | 8-K | $56.59 $61.32 | ▲ +8.36% | ▲ +5.93% | $56.93 (+0.60%) |
Jun 16, 2026 15w ago | Insider Cluster | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 16, 2026 15w ago | 8-K | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 12, 2026 16w ago | 144 | $52.04 $56.59 | ▲ +8.74% | ▲ +6.96% | $56.93 (+9.40%) |
Jun 2, 2026 17w ago | 8-K | $42.96 $56.34 | ▲ +31.15% | ▲ +32.71% | $56.93 (+32.52%) |
May 15, 2026 20w ago | 144 | $42.59 $53.80 | ▲ +26.32% | ▲ +24.20% | $56.93 (+33.67%) |
May 5, 2026 21w ago | 144 | $44.76 $45.20 | ▲ +0.98% | ▼ −1.80% | $56.93 (+27.19%) |
May 4, 2026 21w ago | 144 | $44.80 $42.96 | ▼ −4.11% | ▼ −9.06% | $56.93 (+27.08%) |
May 1, 2026 22w ago | Insider Cluster | $44.12 $45.04 | ▼ −2.09% | ▲ +3.20% | $56.93 (−29.03%) |
Apr 15, 2026 24w ago | 144 | $40.95 $42.84 | ▲ +4.62% | ▼ −1.43% | $56.93 (+39.02%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Mon (64h 59m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access